Translational Genomics Research Institute, Mayo Foundation for Medical Education and Research Assigned Patent for Propentofylline to Treat Glioma
Copyright © Targeted News Service 2018
2018-01-24
ALEXANDRIA, Va., Jan. 24 -- Translational Genomics Research Institute, Phoenix, Arizona, and Mayo Foundation for Medical Education and Research, Rochester, Minnesota, have been assigned a patent (9,872,857) developed by three co-inventors for "methods of using propentofylline to treat glioma and glioblastoma." The co-inventors are Nhan Tran, Phoenix, Arizona, Joseph C. Loftus, Scottsdale, Arizona, and Harshil Dhruv, Phoenix, Arizona. The abstract states: "The invention encompasses methods of tre . . .